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of vascular graft infections, a variety of anti-infectives bound to graft 
materials have been studied in vitro and under experimental in vivo 
conditions. Of these, gelatin-sealed Dacron grafts containing bound 
rifampin appear to have the most favorable pharmacokinetics in vitro. 
Experimental models demonstrate efficacy for the prevention of 
infection following contamination of the graft either directly or 
hematogenously, as well as efilcacy for the treatment of established 
infection when rifanipin-containing grafts are used as part of surgical 
therapy. To date, however, results reported from two randomized 
clinical trials involving over 3100 patients have not shown a statistic- 
ally significant reduction in graft infections. 
Both the incidence of endocarditis and the mortality among 
patients with endocarditis are higher among patients with cardiac 
prosthetic valves than among patients with native cardiac valves. 
Endocarditis affecting prosthetic cardiac valves typically originates in 
the sewing ring. Recently, St Jude prosthetic cardiac valves using 
Dacron sewing rings impregnated with silver (Silzone) have been 
introduced into clinical practice. In vitro, Silzone inhibits attachment 
and growth of microorganisms. A large, international randomized 
clinical trial designed to determine whether Silzone is effective in 
reducing the incidence of prosthetic valve endocarditis is in progress. 
Medical versus surgical therapy in native and 
prosthetic valve endocarditis 
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Infective endocarditis (IE) of native and prosthethic heart valves is still 
burdened by a high mortality. While cumulative survival in uncom- 
plicated IE is 0.93+0.05, manifestation of any of the typical com- 
plications (e.g. congestive heart failure, thromboembolisin. persistent 
sepsis, acute renal failure), vegetation size 10 mni, culture-negative 
endocarditis and a delay in diagnostic decision-making has a signi- 
ficant negative prognostic influence. Early surgical intervention has 
significantly contributed to the overall prognostic improvement 
during the last two decades. Evidence-based experience with more 
than 600 consecutive patients with acute IE has been used to establish 
criteria to determine which patients may benefit from urgent surgical 
intervention: acute aortic regurgitation with lung edema not 
compensated medically within 24 h; acute mitral regurgitation with 
lung edema not compensated by PEEP; ventilation and modulation 
of the left ventricular impedance by sufficient afterload reduction; 
throniboembolic complications (TE) within 30 days after manifest- 
ation of IE, if residual vegetations are demonstrated post-TE; 
recurrent thromboembolic episodes; vegetations larger than 10 mm 
in mitral IE; demonstration of secondary mitral valve involvement in 
aortic IE; sepsis persisting for more than 48 h despite antimicrobial 
therapy; acute renal failure of any etiology; large vegetation size (VS) 
and a high minimal bactericidal concentration (MBC). Medical cure 
rates are low and the risk of complications is high if VS is 10 mm 
and MBC is 1 mg/L. 
Current aspects in anaerobic infections 
Js1681 Antimicrobial resistance in anaerobic bacteria 
E. Nagy. Department cf Clinical Mirrobioloxy, Albert Szent-Gydrgyi 
Medical University, Szeged, Hunpry 
Human pathogenic anaerobic bacteria were susceptible until a few 
years ago to antimicrobial agents used in prophylaxis and treatment 
of anaerobic infections. However, during recent years resistance to 
certain anti-anaerobic drugs has been reported more frequently from 
different parts of the world. The Etest method (more reliable than 
the disk diffusion method) has become available for routine labora- 
tories to evaluate the resistance of clinical isolates to most widely used 
antibiotics. Antibiotic resistance due to beta-lactamase activity is 
observed most frequently among Barfemides jagi l is  group strains; 
however, more and more Prerwtella, Porphyromonas and Fusobactrrium 
strains have been reported to be resistant to different antimicrobial 
agents. The nietallo-beta-lactamase production of B. fragilis is res- 
ponsible for the resistance to carbapenems. The presence of the Cf iA  
gene, coding for this enzyme, has been detected by PCR among 
carbapenem-susceptible strains in different parts of Europe. 
Decreased permeability and modification of the PBPs has also been 
reported as the cause of resistance to cefoxitin, ureidopenicillins and 
inhibitor combinations. Clindainycin resistance among clinically 
important anaerobes varies in different parts of the world. Among 
Gram-negative anaerobes, a low number of strains resistant to 
metronidazole have also been detected in different countries. 
According to the in vitro data, the newest fluoroquinolones, such as 
trovafloxacin, clinafloxacin and grepafloxacin, have considerable anti- 
anaerobic activity, 
Is169] Current aspects of anaerobic infections 
C.E. Nord. University Hospita/, Dept. <flmmuno/ofy, Huddingr, 
Sweden 
The normal human microflora contains both aerobic and anaerobic 
bacteria. The human gastric niucosa is colonized by the inhgenous 
bacteria in low numbers in healthy persons due to the low pH of the 
stomach. The bacteria are also protected from the gastric acid by the 
mucosal layer in the stomach. Impaired gastric secretion causes 
proliferation of acid-tolerant streptococci and lactobacilli. When the 
pH is constantly over 4, proliferation of other anaerobic bacteria such 
as bacteroides and fusobacteria can occur. These bacteria colonize the 
inucosa without any signs of mucosal inflammation, in contrast to 
Helitobacter pylori. It is now accepted that the finding of Heliiobarter 
pylori is associated with gastritis and peptic ulcer disease. Treatments 
for Helicobacter pylori infections include proton pump inhibitors in 
combination with antimicrobial agents with different clinical res- 
ponses. Probiotics containing anaerobic bacteria have also been 
reported to be successful in the treatment of these infections. In 
patients treated with a proton pump inhibitor, anaerobic bacteria 
such as veillonellae, bacteroides and fusobacteria are increased when 
HeliroBacterpylori is significantly decreased. Patients receiving a proton 
pump inhibitor together with antimicrobial agenh have also increased 
numbers of anaerobic bacteria when Helitobacter pylori is eradicated 
from the gastric microflora. Thus, there IS an inverse relationship 
between the anaerobic microflora and Heliiobacter pylori during 
proton pump inhibitor/antimicrobial treatment. 
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Clostridium difficile infection in Europe 
B.I. Duerden, J.S. Brazier. PHLS Anaerobe Reference Unit, Universit]) 
qf Wales College ($Medicine, Card8 UK 
The recorded incidence of Clustridium dficile-associated diarrhea 
(CDAD) continues to increase in most European countries, but sur- 
veillance data are inconsistent and incomplete. O f  nine countries 
represented in the European C. dficile Study Group, only five have 
data on the extent of CDAD and four have national case totals- 
Scotland c. 1000, Finland c. 4000, Sweden c. 8000, and England and 
Wales c. 15 500: The numbers reported in England and Wales have 
increased exponentially during the 1990s. Typing for epidemiologic 
purposes is performed in Scotland, Germany, France, Sweden and 
England and Wales by methods that include serotyping, protein 
banding (PAGE), PFGE, AP-PCR, RFLP and PCR-ribotyping. As 
many diagnoses are made by toxin detection, the availability of 
isolates for typing is limited. Both single-strain outbreaks with cross- 
infection and multi-strain clusters related to broad-spectrum anti- 
biotic usage occur. The PHLS Unit has established a library of 100 
P C R  ribotypes; type 1 is widespread among UK hospitals and may 
represent a clone with enhanced survival or virulence characters. The 
ecology of C. dijjcile requires study Healthy carriage appears to be 
low in European adults but C. d@cile has been isolated from animals, 
soil and water. 
Use of indicators for good infection control 
practice 
Is1711 Which indicators can be useful for the 
judgment of antibiotic strategies for antibiotic 
prophylaxis? 
O.B. Jepsen, L.G. Burman, H. Carsauw, P. Gastmeier, V 
Jurkuvenas, A. Sainz, D.L. Monnet, The European Stratexyfor 
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Present knowledge of the pros and contras of antibiotic prophylaxis 
calls for a restrictive policy, applying validated antibiotic prophylaxis 
to patients only where adequate documentation for the expected 
effect exists. The current literature, however, shows varying strategies 
for the use of prophylactic antibiotics to prevent postoperative wound 
infections in surgical patients and pneumonia in intensive care 
patients, though sufficient scientific verification already exists for a 
range of well-defined clinical situations allowing discrimination 
between appropriate and inappropriate practice. Within the field of 
infection control, the use of clinical monitoring systems has advanced 
to a point where unvalidated applications should be avoided, and the 
time has come where the focus should be on developing relevant 
indicators for easy monitoring. 
The ESAP (European Strategy for Antibiotic Prophylaxis) project 
applies the essence of this experience to examine antibiotic prophy- 
laxis in a sample of surgical and intensive care patients, and includes 
validation techniques to ensure comparability of data. A guideline 
with examples of good antibiotic prophylaxis (GAP), as well as 
indicators for verification of GAP, are expected to emerge from this 
project. Structural indicators referring to department policy, staff 
training and education, as well as process indicators of timing and 
duration of prophylactic treatment, have been found useful in the 
project’s pilot study and are currently being tested in a larger scale 
study. 
Present status and perspectives of the project will be discussed. 
Is172] Experience with indicators of infection control 
(IC) problems in the course of a multicenter 
quality assurance project (NIDEP 2) 
P. Gastnieier. Institutrfor Hygiene, Free Cniversiry Bcrlin, Berliiz, 
Germany 
Objectives: To evaluate inhcators of IC problems. 
Methods: A prospective controlled intervention study was 
performed in the curgical and intensive care units of eight inediuni- 
sized general hospitals. Data on the structure and process quality were 
recorded at the beginning and the end of the study, as well as 
nosocomial infection (NI) rates, accordmg to the C D C  definitions 
(incidence studies over periods of 8 weeks). Four hocpitals with a 
special interest in IC activities were chosen for intervention, the 
remaining four serving as control hospitals. Four physicians trained 
in IC, one in each hospital, analyzed the situation through observa- 
tion and questionnaires, and aimed at optimizing the IC procedures 
over a period of 2 years, in particular by increasing teaching activities. 
Finally, the incidence density rates for NI at the end ofthe study were 
compared with the rates at the beginning and together analyzed with 
the data for a number of recommended indicators of IC problems. 
Results and conclusion: A total of 76 811 patient days was 
registered at the beginning and the end of the study; the overall 
incidence density of NI was 7.5% in the first period and 6.10/;, at the 
end. A prevented fraction of 25.4% NI (CI 95: 6.140.7) was found 
in the four intervcntion hospitals; the prevented fraction in the four 
control hospitals was 10.0% (CI 95: 15.8-30.1). This reduction ofNI  
was not correlated with a corresponding development of the majority 
of indicators of IC problems. Thus it remains dificult to recommend 
simple and reliable indicators of IC problems. 
Results of repeated prevalence surveys: 
indicator of good practice? 
A. Trilla. Hospital Clinic, Hopital Epidemiulqy, Barreloria, Spain 
Prevalence surveys are of great practical and scientific interest with 
regard to the evolution of a variable whenever the results of multiple, 
periodically repeated studies are available. The EPINE study 
(Prevalence Survey of Nosocomial Infections in Spain) hac been 
conducted every year since 1990 in Spanish hospitals, including a 
‘core’ sample of 64 hospitals. This situation allows the analyeis of 
several features of the EPINE study related to the use of prevalence 
surveys as quality or performance indicators for infection control. 
The EPINE provides hospitals with a measure of riosocomial 
infection rates. Although it is an imperfect and limited measure, 
alternative options for most institutions are either complete ignorance 
of any measure of nosocomial infection rates or the conduction of 
time-consuming and expensive incidence studies. The EPINE study 
is endorsed by the Spanish Health Department, and its annual results 
are widely published and well known. Many Spanish hospitals choose 
to perform the EPINE study as the best simple and economic option 
for limited surveillance of nosocomial infections. Are these data 
useful for improving quality of care? Comparisons are difiicult, and 
there are many confounding factors that make this comparison risky. 
Those hospitals with prevalence rates well above (or below) national 
figures will have to look more closely at what is going on with their 
data. This analysis is best approached by internal. benchmarking 
comparisons of historical data within a single institution. Again, 
methodological shortcomings are lurking everywhere, but repeated 
prevalence studies are a valuable and useful source of information. 
